Literature DB >> 8403557

Immunohistological demonstration of transforming growth factor-beta isoforms in the skin of patients with systemic sclerosis.

P P Sfikakis1, B K McCune, M Tsokos, K Aroni, G Vayiopoulos, G C Tsokos.   

Abstract

We investigated the expression of transforming growth factor-beta (TGF-beta) isoforms in involved and uninvolved areas of skin from patients with systemic sclerosis (SSc) and normal controls. Paraffin-embedded skin specimens were stained for TGF-beta 1, TGF-beta 2, and TGF-beta 3 using the avidin-biotin-peroxidase technique. TGF-beta 2 was expressed intensely in the extracellular matrix of the skin biopsies obtained from involved areas of patients with SSc, in contrast to the uninvolved areas and normal individuals. TGF-beta 2 was deposited throughout the entire dermis and also in a linear fashion along the dermoepidermal junction and in the perivascular areas of SSc-involved skin. Although infiltrating mononuclear cells were not present in great numbers, they did not stain for TGF-beta 2. TGF-beta 1 and TGF-beta 3 were not expressed in the extracellular space in either patients or normal controls, except in rare cases. The cellular staining which was observed for all three isoforms did not differ between involved and uninvolved skin and normal controls. The finding of increased deposition of TGF-beta 2 in the involved skin of patients with SSc implies that it may be involved in the pathologic fibrotic process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403557     DOI: 10.1006/clin.1993.1170

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  19 in total

Review 1.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999

2.  MicroRNA expression abnormalities in limited cutaneous scleroderma and diffuse cutaneous scleroderma.

Authors:  Honglin Zhu; Yisha Li; Shunlin Qu; Hui Luo; Yaou Zhou; Yanping Wang; Hongjun Zhao; Yunhui You; Xianzhong Xiao; Xiaoxia Zuo
Journal:  J Clin Immunol       Date:  2012-02-04       Impact factor: 8.317

3.  Mast cells, extracellular matrix components, TGFbeta isoforms and TGFbeta receptor expression in labial salivary glands in systemic sclerosis.

Authors:  G I Mason; J Hamburger; J B Matthews
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 4.  Pharmacotherapy of systemic sclerosis.

Authors:  Arnold E Postlethwaite; L Jeff Harris; Syed H Raza; Swapna Kodura; Titilola Akhigbe
Journal:  Expert Opin Pharmacother       Date:  2010-04       Impact factor: 3.889

5.  The effects of ageing on wound healing: immunolocalisation of growth factors and their receptors in a murine incisional model.

Authors:  G S Ashcroft; M A Horan; M W Ferguson
Journal:  J Anat       Date:  1997-04       Impact factor: 2.610

Review 6.  Transforming growth factor β--at the centre of systemic sclerosis.

Authors:  Robert Lafyatis
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

Review 7.  Gene expression profiling offers insights into the role of innate immune signaling in SSc.

Authors:  Michael E Johnson; Patricia A Pioli; Michael L Whitfield
Journal:  Semin Immunopathol       Date:  2015-07-30       Impact factor: 9.623

8.  Increased frequency of in vivo hprt gene-mutated T cells in the peripheral blood of patients with systemic sclerosis.

Authors:  P P Sfikakis; J Tesar; S Theocharis; G L Klipple; G C Tsokos
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

9.  A TGFbeta-responsive gene signature is associated with a subset of diffuse scleroderma with increased disease severity.

Authors:  Jennifer L Sargent; Ausra Milano; Swati Bhattacharyya; John Varga; M Kari Connolly; Howard Y Chang; Michael L Whitfield
Journal:  J Invest Dermatol       Date:  2009-10-08       Impact factor: 8.551

10.  Plasma TGF beta in systemic sclerosis: a cross-sectional study.

Authors:  N Snowden; B Coupes; A Herrick; K Illingworth; M I Jayson; P E Brenchley
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.